Director/PDMR Shareholding
Summary by AI BETAClose X
Travis Perkins plc (the "Company") announces that :
On 19 March 2026 it was notified of the exercise of nil-cost options and subsequent sale of ordinary shares in the Company of 11.205105p ("Shares") to meet the income tax and national insurance liabilities arising from the exercise of options by Duncan Cooper, Chief Financial Officer and a Person Discharging Managerial Responsibilities ("PDMR"):
|
Name |
Status |
No. of options exercised |
Exercise & sale date |
No. of shares sold |
Price |
No. of shares retained |
|
|
Duncan Cooper |
PDMR |
CFO Buyout Award of 2023 DSBP
|
13,973 |
19 March 2026 |
6,591 |
£5.635634 |
7,382 |
This Notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation, the Notification of Dealing Forms for the PDMR can be found below.
For further information please contact:
Will Lang
Company Secretary
will.lang@travisperkins.co.uk
+44 (0) 7468 713734
Notification of Dealing Form - Exercise of CFO Buyout Award of 2023 DSBP
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name |
Duncan Cooper |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/Status |
Chief Financial Officer/PDMR |
|||
|
b) |
Initial notification/Amendment |
Initial Notification
|
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Travis Perkins plc |
|||
|
b) |
LEI |
2138001I27OUBAF22K83 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and; (iv) each place where transaction have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 11.205105 pence each ISIN: GB00BK9RKT01 |
|||
|
b) |
Nature of the transaction |
Exercise of CFO Buyout Award of 2023 DSBP granted as nil-cost options under the Travis Perkins plc Restricted Share Plan |
|||
|
c) |
Price(s) and volume (s) |
|
|
||
|
Price(s) |
Volume(s) |
||||
|
Nil
|
13,973 |
||||
|
d) |
Aggregated information -Aggregated volume -Price |
|
|
|
|
|
Aggregate Price |
Aggregate Volume |
Aggregate Total |
|||
|
Nil
|
13,973 |
n/a |
|||
|
e) |
Date of the transaction |
19 March 2026 |
|||
|
f) |
Place of the transaction |
Outside a trading venue |
|||
Notification of Dealing Form - subsequent sale of ordinary shares by the PDMR
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
||||
|
a) |
Name |
Duncan Cooper |
|||
|
2 |
Reason for the notification |
||||
|
a) |
Position/Status |
Chief Financial Officer/PDMR |
|||
|
b) |
Initial notification/Amendment |
Initial Notification
|
|||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
||||
|
a) |
Name |
Travis Perkins plc |
|||
|
b) |
LEI |
2138001I27OUBAF22K83 |
|||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and; (iv) each place where transaction have been conducted |
||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary shares of 11.205105 pence each ISIN: GB00BK9RKT01 |
|||
|
b) |
Nature of the transaction |
Sale of ordinary shares to meet income tax and national insurance liabilities falling due on exercise of CFO Buyout Award of 2023 DSBP granted as nil-cost options under the Travis Perkins plc Restricted Share Plan |
|||
|
c) |
Price(s) and volume (s) |
|
|
||
|
Price(s) |
Volume(s) |
||||
|
£5.635634 |
6,591
|
||||
|
d) |
Aggregated information -Aggregated volume -Price |
|
|
|
|
|
Aggregate Price |
Aggregate Volume |
Aggregate Total |
|||
|
£5.635634 |
6,591 |
£37,144.46369
|
|||
|
e) |
Date of the transaction |
19 March 2026 |
|||
|
f) |
Place of the transaction |
XLON |
|||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Latest directors dealings
- 2 hours ago Luceco
- 2 hours ago Helios Towers
- 2 hours ago Wise Class A
- 2 hours ago EDX Medical Group Plc
- 3 hours ago Naked Wines